Finally, the cardioprotective effects (anti-arrhythmic and anti-ischemic effects) of several agents, which are included in optimal guideline-based HF therapy, such as sodium-glucose co-transporter 2 inhibitors, can be mediated by restoring circulating irisin levels [15,55,56,57]. Here, FNDC5 is linked to hydrops fetalis.